Bradley Johnson

Bradley Johnson has extensive work experience in the technology and engineering field. Bradley started their career as a Scientist at Nanǵmix in 2006 and later moved up to become the Director of Engineering in 2011. Bradley then progressed to the role of Senior Director, Technology Development in 2017 and ultimately became the Chief Technology Officer in 2022. Prior to their time at Nanǵmix, Bradley worked at Isis Pharmaceuticals as an Associate Scientist, where they were responsible for mining genomes and developing a bioinformatics pipeline for identifying potential drug therapy targets.

Bradley Johnson pursued their education beginning in 1996 at UC San Diego, where they obtained a Bachelor of Science degree in Bioengineering in the year 2000. Bradley then went on to pursue further studies at the University of California, Berkeley, from 2000 to 2006, where they obtained a PhD in Bioengineering.